Last reviewed · How we verify
NCT05428748
Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers
NA trial testing 1 serving of test product in Tolerance in 40 participants. Completed in 1 March 2023.
1 February 2023
Quick facts
| Lead sponsor | Liquid I.V. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 40 |
| Start date | 1 September 2022 |
| Primary completion | 1 February 2023 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 1 serving of test product
- 2 servings of test product
- 3 servings of test product
- Placebo
Conditions studied
- Tolerance — all drugs for Tolerance →
Sponsor
Liquid I.V.
Who can join
Adults 18 to 35, any sex, with Tolerance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial design aims to evaluate the safety and tolerability of a novel hydration drink in health volunteers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05428748
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tolerance
Currently open trials in the same condition.
- NCT06189170 — Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients · EARLY_PHASE1 · recruiting
- NCT05644717 — Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD · Phase 4 · recruiting
- NCT05022420 — SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases · recruiting
- NCT06286488 — Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza · Phase 4 · active not recruiting
Other Liquid I.V. trials
Trials by the same sponsor.
- NCT06524674 — Clinical Study to Compare the Effect of an Oral Rehydration Solution on the Rate of Absorption of Functional Ingredients · NA · completed
- NCT05428228 — Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults · NA · recruiting
- NCT05428761 — Clinical Trial to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults · NA · completed
- NCT05428774 — Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05428748 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liquid I.V.
- Last refreshed: 29 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05428748.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing